Keyphrases
Pan-cancer Analysis
83%
Whole Genome
77%
Tumor
41%
Human Cancer
29%
In Cancer
26%
Cancer Types
25%
Cancer Genome Atlas
24%
Molecular Characterization
23%
DNA Methylation (DNAm)
19%
Nivolumab
17%
Programmed Death-ligand 1 (PD-L1)
16%
Tumor Microenvironment
15%
Genetic Modification
13%
Pan-cancer
13%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
13%
Overall Survival
12%
Tumor Subtype
12%
Anti-PD-1
11%
Driver mutations
11%
Structural Variants
10%
Cancer Genome
10%
Gene Expression
10%
Hepatocellular Carcinoma
9%
Genomic Characterization
9%
Mitochondrial DNA
9%
Apologizing
9%
Anti-PD-1 Therapy
8%
Pancreatic Ductal Adenocarcinoma
8%
Methylation
8%
Genome Rearrangement
7%
Lung Cancer
7%
Neoantigen
7%
Tumor Immunity
7%
Molecular Classification
7%
Genome Analysis
7%
Cancer Drivers
6%
Immune Checkpoint Inhibitors
6%
Cancer Cells
6%
Epigenetic Modification
6%
Mutation Pattern
6%
Aneuploidy
6%
Whole Genome Sequencing
6%
Renal Cell Carcinoma
6%
Multi-omics Analysis
6%
Impact Test
6%
Deep Learning System
6%
Cancer Cell Populations
6%
Multiple Sclerosis Treatment
6%
Mutational Processes
6%
Metastatic Cancer
6%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
48%
Gene Expression
42%
Oncogene
34%
Whole Genome Sequencing
32%
Epigenetics
31%
Cancer Cell
30%
Methylation
24%
Carcinogenesis
22%
T Cell
21%
Signal Transduction
17%
PD-L1
16%
Immune Checkpoints
16%
Wart Virus
15%
Messenger RNA
15%
Transcriptomics
14%
Long Non-Coding RNA
14%
MicroRNA
13%
Promoter Region
13%
Transcriptome
12%
Tumor Gene
12%
Alternative Splicing
11%
Gene Expression Profiling
11%
RNA Sequence
11%
RNA Sequencing
10%
Gene Mutation
10%
Exome
10%
Tumor Suppressor Protein
10%
Genetics
9%
DNA RNA Hybridization
9%
Somatic Mutation
9%
Mutational Load
9%
RNA
9%
Overall Survival
8%
Proteomics
8%
Wild Type
8%
Metabolic Pathway
8%
Aneuploidy
8%
Gene Fusion
8%
Stem Cell
8%
Enhancer Region
8%
Mutated Genes
8%
Long Noncoding RNA
8%
Immunocompetent Cell
7%
CD4
7%
BAP1
7%
Phosphotransferase
7%
Kinase
7%
CD8
7%
CpG Island
7%
Prevalence
6%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
93%
The Cancer Genome Atlas
25%
Cancer Types
21%
Biological Marker
20%
Nivolumab
17%
Tumor Microenvironment
16%
T Cell
14%
Programmed Death-Ligand 1
14%
Hepatocellular Carcinoma
12%
Tamsulosin
12%
Pancreas Adenocarcinoma
12%
Gene Expression
12%
Somatics
12%
Methylation
11%
Metastatic Carcinoma
11%
Disease
11%
CD8 Antigen
10%
Nodular Melanoma
10%
Cancer Cell
9%
Clear Cell Renal Cell Carcinoma
9%
Pancreas Cancer
9%
DNA Methylation
8%
Carcinogenesis
8%
Overall Survival
8%
Immunotherapy
8%
Programmed Cell Death
8%
Colorectal Cancer
8%
Primary Tumor
7%
Clinical Trial
7%
Transcriptomics
7%
Programmed Death 1 Ligand 1
7%
Oncogene
7%
Lung Cancer
7%
Immune Checkpoint Inhibitor
6%
Tumor Immune Microenvironment
6%
Cabozantinib
6%
Alternative RNA Splicing
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Entinostat
6%
Merkel Cell Carcinoma
6%
Oncology
6%
RNA Sequence
6%
Medicine
6%
Promoter Region
5%
Immunosuppressive Drug
5%
Gene Expression Profiling
5%
Aneuploidy
5%
Tumor Gene
5%
Immunohistochemistry
5%
